Blueshift Asset Management’s Gilead Sciences GILD Stock Holding History

Blueshift Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,446	Closed	-$326K	–	365
2024 Q1	$326K	Buy	+4,446	New	+$342K	0.17%	189
2023 Q3	–	Sell	-5,001	Closed	-$385K	–	329
2023 Q2	$385K	Buy	5,001 +2,130	+74%	+$170K	0.15%	171
2023 Q1	$238K	Buy	+2,871	New	+$238K	0.1%	269
2022 Q2	–	Sell	-46,496	Closed	-$2.76M	–	798
2022 Q1	$2.76M	Buy	46,496 +37,078	+394%	+$2.37M	0.25%	107
2021 Q4	$684K	Buy	9,418 +5,852	+164%	+$403K	0.06%	383
2021 Q3	$249K	Buy	+3,566	New	+$251K	0.01%	878
2021 Q2	–	Sell	-8,605	Closed	-$556K	–	1003
2021 Q1	$556K	Buy	+8,605	New	+$555K	0.06%	437
2019 Q4	–	Sell	-10,254	Closed	-$650K	–	871
2019 Q3	$650K	Buy	10,254 +6,666	+186%	+$436K	0.1%	296
2019 Q2	$242K	Buy	+3,588	New	+$236K	0.03%	612

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blueshift Asset Management's GILD Position: Q2 2024 in Review

Blueshift Asset Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 4,446 shares — an estimated $326K sold.

Blueshift Asset Management first reported a position in GILD in Q2 2019 and held it in 9 quarters. The position peaked at $2.76M in Q1 2022. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

Blueshift Asset Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
Blueshift Asset Management sold 4,446 Gilead Sciences shares in Q2 2024, an estimated $326K.
Blueshift Asset Management first reported a position in Gilead Sciences in Q2 2019 and held it in 9 quarters.
Blueshift Asset Management's Gilead Sciences position peaked at $2.76M in Q1 2022.
1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Blueshift Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.